Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 202.47 | N/A |
| PEG Ratio (TTM) | 0.63 | N/A |
| P/S Ratio (TTM) | 3.56 | N/A |
| P/B Ratio (TTM) | 2.31 | N/A |
| P/FCF Ratio (TTM) | 26.26 | N/A |
| Price to 5YR AVG Earnings Ratio | -678.31 | N/A |
| Price to 5YR AVG FCF Ratio | 32.08 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.46% | N/A |
| ROE (TTM) | 1.16% | N/A |
| Net Profit Margin (TTM) | 1.76% | N/A |
| ROIC 5YR AVG | 3.52% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 125.92% | -39.16% | -56.05% |
| Revenue | 4.08% | 69.98% | 53.49% |
| Net Income | 124.03% | 8.36% | -26.66% |
| Cash Flow | 99.47% | 187.92% | 112.47% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.04 | N/A |
| Quick Ratio (TTM) | 1.03 | N/A |
| D/E Ratio (TTM) | 0.60 | N/A |
| Interest Coverage (TTM) | 1.61 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 1.24 | N/A |
| LTL to 5YR AVG FCF | 8.32 | N/A |
| Shares Outstanding Growth 5YR AVG | 15.88% | N/A |